Pages that link to "Q34655810"
Jump to navigation
Jump to search
The following pages link to The evolution of drug-resistant malaria: the role of drug elimination half-life (Q34655810):
Displaying 50 items.
- Ongoing challenges in the management of malaria (Q17485687) (← links)
- Challenges of drug-resistant malaria (Q21032482) (← links)
- Antimalarial drug resistance (Q22061790) (← links)
- Evolution of resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum (Q24563685) (← links)
- Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems (Q27000750) (← links)
- Mathematical Modelling to Guide Drug Development for Malaria Elimination (Q28067367) (← links)
- Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria (Q28468762) (← links)
- Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity (Q28474141) (← links)
- Improving pharmacokinetic-pharmacodynamic modeling to investigate anti-infective chemotherapy with application to the current generation of antimalarial drugs (Q28534701) (← links)
- A population genetic model for the initial spread of partially resistant malaria parasites under anti-malarial combination therapy and weak intrahost competition (Q28540567) (← links)
- Changing Malaria Prevalence on the Kenyan Coast since 1974: Climate, Drugs and Vector Control (Q28548617) (← links)
- Benefits of using multiple first-line therapies against malaria (Q30483653) (← links)
- Artesunate and dihydroartemisinin (DHA): unusual decomposition products formed under mild conditions and comments on the fitness of DHA as an antimalarial drug (Q31121606) (← links)
- The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy (Q33576860) (← links)
- Therapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest Ethiopia (Q33605847) (← links)
- Probability of emergence of antimalarial resistance in different stages of the parasite life cycle. (Q33892979) (← links)
- An orthology-based analysis of pathogenic protozoa impacting global health: an improved comparative genomics approach with prokaryotes and model eukaryote orthologs (Q33942047) (← links)
- Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine (Q34014169) (← links)
- An analytical model for genetic hitchhiking in the evolution of antimalarial drug resistance (Q34044092) (← links)
- Modelling parasite drug resistance: lessons for management and control strategies. (Q34434816) (← links)
- The global distribution and population at risk of malaria: past, present, and future (Q34548302) (← links)
- Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis (Q34677891) (← links)
- Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study (Q34728230) (← links)
- The effect of intermittent preventive treatment on anti-malarial drug resistance spread in areas with population movement (Q34894294) (← links)
- Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials (Q34939414) (← links)
- Plasmodium falciparum infection dynamics and transmission potential following treatment with sulfadoxine-pyrimethamine (Q35069824) (← links)
- The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP artesunate combination (Q35541212) (← links)
- History, dynamics, and public health importance of malaria parasite resistance (Q35545447) (← links)
- Chemoresistance in falciparum malaria (Q35547431) (← links)
- Approximations for the hitchhiking effect caused by the evolution of antimalarial-drug resistance. (Q35622064) (← links)
- Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance (Q35699612) (← links)
- Malaria ecology along the Thailand-Myanmar border (Q35799623) (← links)
- Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM study (Q35802773) (← links)
- Measuring windows of selection for anti-malarial drug treatments (Q35906652) (← links)
- Evolutionary biology and the avoidance of antimicrobial resistance (Q35960770) (← links)
- Genetic analysis of the dihydrofolate reductase-thymidylate synthase gene from geographically diverse isolates of Plasmodium malariae (Q36094953) (← links)
- Exploring the folate pathway in Plasmodium falciparum (Q36104143) (← links)
- Drug resistance hampers our capacity to roll back malaria (Q36201223) (← links)
- Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model (Q36288932) (← links)
- Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. (Q36422652) (← links)
- How antimalarial drug resistance affects post-treatment prophylaxis (Q36478207) (← links)
- Resisting resistance: dealing with the irrepressible problem of malaria (Q36488236) (← links)
- Policy options for deploying anti-malarial drugs in endemic countries: a population genetics approach. (Q36538998) (← links)
- Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread (Q36722524) (← links)
- Quantifying the pharmacology of antimalarial drug combination therapy. (Q37283299) (← links)
- Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development (Q37587440) (← links)
- Pharmacological considerations in the design of anti-malarial drug combination therapies - is matching half-lives enough? (Q37685088) (← links)
- Genetics of chloroquine-resistant malaria: a haplotypic view (Q37734142) (← links)
- Scaling up of intermittent preventive treatment of malaria in pregnancy using sulphadoxine-pyrimethamine: prospects and challenges (Q37738205) (← links)
- Intermittent preventive treatment against malaria: an update (Q37747411) (← links)